Core Viewpoint - Glenstar Minerals Inc. has announced promising assay results from its Wildhorse Project, indicating significant gold and silver mineralization, which lays the groundwork for an expanded Phase 2 exploration program [1][5][7]. Group 1: Assay Results - The assay results from twenty-nine stream sediment samples revealed gold at 11.20 g/t and silver at 11.35 g/t, along with notable copper, tungsten, bismuth, and tellurium signatures [1][5]. - Strong tungsten-bismuth anomalies were identified in four distinct stream drainages, confirming known mineralized zones and highlighting two additional prospective drainages [2][3]. Group 2: Geological Insights - The results support the intrusive-center geologic model at Wildhorse, particularly around Palomino Hill, where strong mineralization of gold, copper, silver, bismuth, tellurium, and tungsten was observed [3][4]. - The mineralization pattern aligns with classic metal zoning seen in intrusive-center related ore deposits, similar to those in nearby Nevada districts [4]. Group 3: Project Background - The Wildhorse Property consists of 61 mineral claims covering 1,220 acres in Mineral County, Nevada, with historical workings dating back to the late 1800s [8]. - Initial assessments indicated a series of east-dipping mineralized zones, with previous sampling showing over 1 g/t gold and significant copper and antimony levels [8][9]. Group 4: Future Exploration Plans - The project geologist emphasized the need for an expanded and comprehensive Phase 2 exploration plan to better understand the mineralization in the identified zones [7][6]. - The economic potential of the Wildhorse Project suggests the possibility of discovering a large, well-mineralized skarn system, which is favorable for exploration using various geophysical methods [10].

Core Viewpoint - Phio Pharmaceuticals is advancing its clinical-stage siRNA gene silencing technology, INTASYL, aimed at treating skin cancer, with a focus on its lead product candidate PH-762, which is currently in a Phase 1b clinical trial [1][4]. Group 1: Company Overview - Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company listed on NASDAQ under the ticker PHIO, specializing in therapeutics that utilize its proprietary INTASYL® siRNA gene silencing technology [1][4]. - The company's lead clinical program, PH-762, targets the PD-1 gene associated with various skin cancers, including cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma [4]. Group 2: Clinical Trial Progress - The ongoing Phase 1b clinical trial for PH-762 is currently treating patients in its fifth cohort, indicating progress towards the anticipated final cohort [1][2]. - The trial is designed to evaluate PH-762 as a potential non-surgical treatment option for skin cancers [4]. Group 3: Upcoming Events - Phio Pharmaceuticals will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8 to 10, 2025, where the CEO will provide updates on the clinical trial and future strategies [1][2][8]. - One-on-one investor meetings will be available during the conference for interested parties [3].

OS Therapies to Participate in Upcoming Investor Conferences in September 2025September 03, 2025 7:40 AM EDT | Source: OS TherapiesNew York, New York--(Newsfile Corp. - September 3, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it will participate in the upcoming investor conferences:Cantor Global Healthcare Conference 2025 being held September 3-5, ...

Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") is pleased to announce that it has acquired, through map staking, 114,084 hectares of mineral claims approximately 25km north of Borden Lake in Ontario (the "KSZ Project"). About the KSZ ProjectThe KSZ Project encompasses a prospective region within the Abitibi-Wawa Sub-province of the Archean Superior Province. The geology is characterized by str ...

Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant DepressionExport of 1,000 natural psilocybin capsules for prescription use under Australia's Authorised Prescriber Scheme follows the Company's successful launch of MDMA sales in 2024September 03, 2025 7:30 AM EDT | Source: Optimi Health Corp.Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadia ...

Founders Metals Hits Deep High-Grade Mineralization at Upper Antino; 18.0 m of 6.14 g/t Gold from 450 mSeptember 03, 2025 7:30 AM EDT | Source: Founders Metals Inc.Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") is pleased to announce drill core assay results from its ongoing, fully funded 60,000 metre drilling campaign at the Antino Gold Project in southeastern Suriname (Figure 1). Th ...

Core Insights - Onyx Gold Corp. has reported significant drill results from its Munro-Croesus Project, confirming the vertical and lateral extensions of the Argus North Zone, indicating a large-scale and continuous gold mineralization system [1][6][24] Drilling Results - The latest drilling results include 91.0 meters grading 1.1 g/t Au and 103.4 meters grading 1.1 g/t Au in drill hole MC25-177, contributing to a cumulative mineralization thickness of 194.4 meters [5][11] - Additional notable results include 139.1 meters grading 0.8 g/t Au in drill hole MC25-181 and 9.8 meters grading 2.9 g/t Au in drill hole MC25-174 [5][12] - The drilling program has completed 48 holes, with assays announced for 15 holes, covering approximately 15,000 meters, which is 60% of the planned 25,000-meter program [5][12] Project Overview - The Munro-Croesus Project is strategically located along Highway 101 in the Abitibi greenstone belt, a prominent gold mining region in Canada, and includes the historically significant Croesus Gold Mine [24][25] - The project area covers 109 km² of highly prospective geology, with significant nearby gold deposits enhancing its exploration potential [24][25] Future Plans - The Argus North Zone remains open along strike, down-dip, and down-plunge, with ongoing plans for step-out drilling to further extend the known gold mineralization [6][10][11] - The company is fully funded for its 2025 exploration programs with approximately $10 million in cash [5][12]

Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) ("ReGen III" or the "Company"), a leading clean technology company specializing in the upcycling of used motor oil ("UMO") into high-value Group III base oils, is pleased to present its second quarter update, available in video here. Key HighlightsEnhanced Commercial and Strategic Partnership Engagement ReGen III has intensified its focus on offtake and strategic partnerships, which remain a top ...

First Phosphate Provides Commercial Results for LFP Battery Cells Produced Using North American Critical MineralsSeptember 03, 2025 7:07 AM EDT | Source: First Phosphate Corp.Saguenay, Quebec--(Newsfile Corp. - September 3, 2025) - First Phosphate Corp. (CSE: PHOS) (OTCQX: FRSPF) (FSE: KD0) ("First Phosphate" or the "Company") announced on July 7, 2025 that it had successfully produced commercial-grade lithium iron phosphate ("LFP") 18650 format battery cells ("PHOS - LFP 18650 Battery Cells") ...

Core Insights - Thermal Energy International Inc. will participate in two upcoming investor conferences: the Smallcap Discoveries Conference in Vancouver and the Planet MicroCap Showcase in Toronto [1][2] Group 1: Conference Details - The Smallcap Discoveries Conference will take place on September 29, 2025, with Thermal Energy's presentation scheduled for 11 am PT at JW Marriott Parq Vancouver [2] - The Planet MicroCap Showcase is set for October 22, 2025, where Thermal Energy will present at 10 am ET at Arcadian Court & Loft, Toronto [2] Group 2: Company Overview - Thermal Energy provides energy efficiency and emissions reduction solutions to Fortune 500 and large multinational companies, focusing on reducing fuel use and carbon emissions [3][4] - The company's proprietary solutions can recover up to 80% of energy lost in typical boiler plant and steam system operations, offering a high return on investment with a short payback period [3] - Thermal Energy operates as a fully accredited professional engineering firm with offices in Ottawa, Pittsburgh, and Bristol, and sales offices across several countries including Canada, the UK, the USA, Germany, Poland, and Italy [4]